BIOCON LIMITED IN

Biocon Limited Company Profile

Nature of Business: Manufacturer

Biocon Limited is an Indian biopharmaceutical company headquartered in Bengaluru, India. It is a leading global biopharmaceutical enterprise that develops, manufactures, and markets advanced therapies, including novel biologics, biosimilar insulins, and other biopharmaceutical products. The company focuses on therapeutic areas such as diabetes, oncology, and immunology. Biocon operates extensive research and development facilities and manufacturing plants, making it primarily a manufacturer of pharmaceutical products and active pharmaceutical ingredients (APIs). While it also engages in the commercialization and distribution of its products, its core business model and identity are rooted in manufacturing and innovation.

Company: BIOCON LIMITED

Products Manufactured or Sold:

Biocon Limited produces and sells a diverse portfolio of biopharmaceutical products. These include:

1. Recombinant Human Insulin and its analogues such as Insulin Glargine and Insulin Aspart.

2. Biosimilars for various therapeutic areas including oncology, immunology, and ophthalmology. Examples include Trastuzumab for breast cancer, Pegfilgrastim for neutropenia, Bevacizumab for various cancers, Adalimumab for autoimmune diseases, Etanercept for autoimmune diseases, Rituximab for lymphoma and autoimmune diseases, and Aflibercept for ophthalmology.

3. Small molecule formulations covering therapeutic areas such as immunosuppression (e.g., Tacrolimus, Mycophenolate Mofetil), cardiovascular health (e.g., statins like Rosuvastatin, Atorvastatin), diabetes (e.g., oral hypoglycemics like Metformin), oncology (e.g., Erlotinib, Lenalidomide), and nephrology.

4. Active Pharmaceutical Ingredients (APIs) which are key ingredients for their own formulations and supplied to other pharmaceutical companies.